Journal of Biomedical Research

Scope & Guideline

Fostering Interdisciplinary Research for Improved Health Outcomes

Introduction

Welcome to your portal for understanding Journal of Biomedical Research, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1674-8301
PublisherNANJING MEDICAL UNIV
Support Open AccessNo
CountryChina
TypeJournal
Convergefrom 2010 to 2024
AbbreviationJ BIOMED RES / J. Biomed. Res.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address140, HANZHONG LU, NANJING 210029, PEOPLES R CHINA

Aims and Scopes

The Journal of Biomedical Research focuses on advancing knowledge in the field of biomedical sciences through innovative research methodologies and interdisciplinary approaches. It emphasizes the integration of clinical and laboratory findings to enhance our understanding of disease mechanisms and therapeutic strategies.
  1. Cancer Biology and Therapeutics:
    The journal features extensive research on cancer biology, including molecular mechanisms of tumorigenesis, genetic predispositions, and novel therapeutic strategies targeting various cancers.
  2. Genetics and Genomics:
    A significant emphasis on genetic variants and their implications for disease risk, particularly in cancer, highlights the journal's focus on genomics and personalized medicine.
  3. Immunology and Inflammation:
    Studies exploring immune system interactions, inflammatory processes, and their roles in disease progression are prevalent, indicating a strong focus on immunological aspects of health and disease.
  4. Neuroscience and Neurodegenerative Diseases:
    Research related to neurobiology, neurodegeneration, and the mechanisms underlying cognitive decline demonstrates the journal's commitment to advancing knowledge in neuroscience.
  5. Translational Medicine:
    The journal emphasizes translational research that bridges laboratory discoveries with clinical applications, focusing on improving patient outcomes through innovative therapies.
  6. Regenerative Medicine and Cell Therapy:
    Research on stem cells, tissue engineering, and regenerative therapies reflects the journal's dedication to exploring cutting-edge approaches in biomedical research.
  7. Clinical and Epidemiological Studies:
    The inclusion of clinical trials, epidemiological studies, and real-world evidence highlights the journal's commitment to addressing public health challenges and improving clinical practices.
The Journal of Biomedical Research has demonstrated a dynamic evolution in its thematic focus, highlighting several emerging trends that resonate with current scientific advancements and societal health challenges.
  1. Precision Medicine:
    An increasing number of studies are exploring precision medicine approaches, utilizing genetic and molecular profiling to tailor therapies to individual patients, reflecting the shift towards personalized healthcare.
  2. Artificial Intelligence in Healthcare:
    There is a growing trend in the application of artificial intelligence and machine learning techniques for diagnostics, treatment planning, and drug discovery, indicating a significant technological advancement in biomedical research.
  3. Microbiome Research:
    Research exploring the role of the microbiome in health and disease, particularly its implications for neurodegenerative diseases and metabolic disorders, is emerging as a critical area of focus.
  4. Regenerative and Stem Cell Therapies:
    A notable increase in studies related to regenerative medicine and stem cell therapies reflects a growing interest in developing innovative treatments for degenerative conditions.
  5. Cancer Immunotherapy:
    The journal is increasingly publishing research on immunotherapy approaches for cancer treatment, including novel immune checkpoint inhibitors and personalized vaccine strategies.
  6. Longitudinal and Real-World Data Studies:
    An uptick in studies utilizing longitudinal and real-world data to assess treatment outcomes and disease progression signifies a trend towards evidence-based clinical research.

Declining or Waning

While the Journal of Biomedical Research continues to thrive in many areas, certain themes have seen a decline in focus over the recent years. This shift may reflect evolving research priorities and advancements in the biomedical field.
  1. Traditional Pharmacology:
    Research centered on conventional pharmacological approaches appears to be decreasing, as the focus shifts towards personalized and targeted therapies.
  2. Basic Laboratory Techniques:
    There has been a noticeable decline in publications dedicated solely to basic laboratory techniques, reflecting a trend towards more complex, integrated methodologies and applications.
  3. Animal Models in Drug Development:
    The use of animal models in drug development studies is becoming less prominent, possibly due to a growing emphasis on alternative methods and ethical considerations.
  4. Infectious Diseases Research:
    While still relevant, the frequency of studies specifically addressing infectious diseases has waned, potentially due to the journal's broader focus on chronic diseases and oncology.
  5. Conventional Imaging Techniques:
    Research involving traditional imaging techniques has decreased, with a clear shift towards advanced imaging modalities and computational methods.

Similar Journals

Life Science Alliance

Fostering Collaboration for a Healthier Tomorrow.
Publisher: LIFE SCIENCE ALLIANCE LLCISSN: Frequency: 6 issues/year

Life Science Alliance, published by LIFE SCIENCE ALLIANCE LLC, is a premier open access journal that has been making significant contributions to the fields of Biochemistry, Genetics and Molecular Biology, Ecology, Health, Toxicology and Mutagenesis, and Plant Science since its inception in 2018. With an impressive ranking in Scopus, including Q1 quartile positions and high percentiles in relevant categories, this journal is a vital resource for researchers, professionals, and students alike who seek to advance knowledge and innovation in life sciences. The journal operates on an open access model, ensuring that research findings are freely available to the global scientific community, thereby enhancing the visibility and impact of published work. With a commitment to fostering collaboration and disseminating high-quality research, Life Science Alliance serves as an essential platform for the promotion and exchange of scientific knowledge, aiming to bridge gaps and stimulate discussions across multiple disciplines.

EXPERIMENTAL AND MOLECULAR MEDICINE

Pioneering discoveries in biochemistry and molecular biology.
Publisher: SPRINGERNATUREISSN: 1226-3613Frequency: 12 issues/year

EXPERIMENTAL AND MOLECULAR MEDICINE, published by SpringerNature, is a premier open-access journal that has been at the forefront of biomedical research since its establishment in 1996. With a focus on innovative studies in biochemistry, molecular biology, and clinical biochemistry, the journal has consistently maintained a distinguished position within the top quartile (Q1) across multiple categories, underscoring its significant impact in these fields. The journal offers researchers and practitioners a platform for high-quality, peer-reviewed articles that advance our understanding of molecular mechanisms underlying health and disease. As a crucial resource for scholars seeking to explore cutting-edge research and practical advancements, its inclusion in relevant databases such as Scopus reflects an exceptional ranking with notable percentiles—placing it among the best in biomedical sciences. With a commitment to open access, EXPERIMENTAL AND MOLECULAR MEDICINE ensures that findings are readily available to the global academic community, facilitating collaboration and innovation in molecular medicine.

BIOCELL

Innovative Insights into Cellular Mechanisms
Publisher: TECH SCIENCE PRESSISSN: 0327-9545Frequency: 12 issues/year

BIOCELL is a distinguished peer-reviewed journal dedicated to the field of Cell Biology, published by TECH SCIENCE PRESS. Since its inception in 1995, the journal has been at the forefront of disseminating innovative research, with converged publication years extending from 1995 to 2013 and from 2015 to 2024. Although it currently holds a Q4 ranking in the Cell Biology category according to the 2023 category quartiles, BIOCELL aims to foster advancements by providing a platform for researchers, professionals, and students to share their findings in biochemistry, genetics, and molecular biology. The journal is available in both print (ISSN: 0327-9545) and digital formats (E-ISSN: 1667-5746) and seeks to attract contributions that enhance scholarly dialogue and understandings of cellular mechanisms and innovations. With a commitment to quality research and critical discourse, BIOCELL plays an important role in nurturing the scientific community within Argentina and beyond, offering vital insights that contribute to the advancement of the life sciences.

Inflammation and Regeneration

Empowering discoveries in inflammation and regenerative therapies.
Publisher: BMCISSN: Frequency: 1 issue/year

Inflammation and Regeneration is a prominent open-access journal published by BMC, focused on the discerning fields of immunology, cell biology, and regenerative medicine. Since its establishment in 2016, the journal has provided a platform for the dissemination of high-quality research, contributing significantly to the advancement of knowledge in inflammation processes and regenerative therapies. With a remarkable impact reflected in its Q1 quartile rankings in Cell Biology and Immunology for 2023, Inflammation and Regeneration stands out as a leading resource for researchers and practitioners. The journal's commitment to open access ensures that critical findings are readily available to a global audience, fostering collaboration and innovation in the scientific community. With a Scopus ranking that places it in the top 20% of its categories, Inflammation and Regeneration serves as an essential reference for those seeking to stay at the forefront of immunological research and its applications.

FASEB JOURNAL

Exploring Molecular Mechanisms for a Healthier Future
Publisher: WILEYISSN: 0892-6638Frequency: 12 issues/year

FASEB JOURNAL, published by Wiley, stands as a leading interdisciplinary platform in the realm of biological sciences, prominently featured in the United States. With an impressive 2023 impact factor placing it in the Q1 category across various fields including Biochemistry, Biotechnology, Genetics, Molecular Biology, and Medicine (miscellaneous), the journal is recognized for its substantial contribution to advancing knowledge and innovation. It serves as a vital resource for researchers, professionals, and students alike, providing high-quality, peer-reviewed articles that explore the molecular and cellular mechanisms underlying health and disease. The FASEB JOURNAL not only emphasizes accessible scientific communication but also fosters collaboration within these dynamic fields, making it an essential publication for anyone engaged in cutting-edge life sciences research. To explore more about the journal's offerings and access its vast repository of scholarly articles, visit their official page.

CELL RESEARCH

Advancing the Frontiers of Cell Biology
Publisher: SPRINGERNATUREISSN: 1001-0602Frequency: 12 issues/year

CELL RESEARCH is a premier peer-reviewed journal dedicated to advancing the field of cell biology and molecular biology, published by SpringerNature. With an impressive impact factor and consistently ranking in the Q1 quartile for both cell biology and molecular biology, this journal serves as a pivotal resource for researchers, professionals, and students seeking to explore the latest discoveries and advancements in cellular mechanisms and their implications for health and disease. Since its inception in 1996, CELL RESEARCH has cultivated a distinguished reputation, currently boasting ranks in the top percentile of Scopus categories, reaffirming its influence and relevance to the scientific community. Although it is not an Open Access journal, its rigorous selection process ensures the publication of high-quality articles that contribute significantly to our understanding of life sciences. For those deeply engaged in the realms of biochemistry, genetics, and molecular biology, CELL RESEARCH is an essential conduit of innovative research and critical insights.

Cell and Bioscience

Connecting Researchers to Transformative Discoveries
Publisher: BMCISSN: Frequency: 1 issue/year

Cell and Bioscience is a prestigious open-access journal published by BMC that has been at the forefront of biochemistry, genetics, and molecular biology since its inception in 2011. With an impressive impact factor, this journal has established itself as a vital resource for researchers and professionals in these rapidly advancing fields, reflecting its high ranking of #29 out of 221 in the Scopus classification and placing it in the 87th percentile. Based in the United Kingdom, Cell and Bioscience aims to foster innovation and dissemination of research findings addressing critical biological questions through rigorous peer-reviewed articles and inter-disciplinary approaches. The journal's open-access model ensures unrestricted access to transformative research, promoting collaboration and knowledge sharing among academics, students, and practitioners worldwide. With a commitment to maintaining excellence in the field, Cell and Bioscience provides an essential platform for those looking to contribute to the evolving landscape of biosciences.

BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH

Unlocking Innovations in Health Sciences
Publisher: ASSOC BRAS DIVULG CIENTIFICAISSN: 0100-879XFrequency: 12 issues/year

The BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, published by the ASSOC BRAS DIVULG CIENTIFICA, serves as a vital platform for the dissemination of cutting-edge research in the fields of medicine and biological sciences. With an ISSN of 0100-879X and E-ISSN 1414-431X, this Open Access journal has been championing free access to vital scientific knowledge since 1997. It is indexed in Scopus with notable rankings across various disciplines, including a rank of #131 in General Medicine (79th percentile) and #20 in Pharmacology, Toxicology, and Pharmaceutics (75th percentile). Covering a broad scope of topics, the journal primarily focuses on areas such as biochemistry, biophysics, immunology, neuroscience, and physiology, with a commendable categorization of Q2 and Q3 quartiles for several relevant fields in 2023. Through its commitment to high-quality research and robust peer review processes, the journal not only consolidates its reputation within the academic community but also significantly contributes to the enhancement of scientific knowledge and innovation in Brazil and beyond. Researchers, professionals, and students will find an invaluable resource in this journal, which is pivotal for those looking to stay abreast of the latest developments in medical and biological research.

Cell Reports Medicine

Pioneering the future of healthcare with cutting-edge insights.
Publisher: CELL PRESSISSN: 2666-3791Frequency: 12 issues/year

Cell Reports Medicine, published by Cell Press, represents a pivotal advancement in the open access landscape of biomedical research since its inception in 2020. With a dedicated focus on the intersection of medicine, biochemistry, genetics, and molecular biology, this journal has quickly established itself as a key resource, earning a remarkable Q1 ranking in these fields. Based in the United States, Cell Reports Medicine boasts impressive metrics, ranking #25 out of 636 in General Medicine and #18 out of 221 in Biochemistry, underscoring its influence and reach within the scientific community, with a notable 96th and 92nd percentile respectively. As a fully open access journal, it fosters global dissemination of knowledge, ensuring that groundbreaking research is readily available to researchers, professionals, and students alike. The journal not only promotes high-quality research but also aims to bridge the gap between molecular discoveries and clinical applications, making it an essential addition to any academic library or researcher's toolkit.

Genes & Diseases

Unlocking the secrets of genes to combat diseases.
Publisher: KEAI PUBLISHING LTDISSN: 2352-4820Frequency: 6 issues/year

Genes & Diseases, published by KEAI PUBLISHING LTD, is a premier open-access journal dedicated to advancing the fields of genetics, biochemistry, and molecular biology. Established in 2014 and headquartered in Beijing, China, this journal has quickly risen to prominence, securing a place in the prestigious Q1 quartile in Biochemistry and Genetics (clinical), as well as Q2 in Cell Biology and Q1 in Molecular Biology as of 2023. With a commitment to disseminating cutting-edge research, Genes & Diseases serves as a critical platform for researchers, professionals, and students alike, ensuring that high-quality scientific work is openly accessible to the global community. The journal's exceptional impact is underscored by its selective Scopus rankings, which reflect its influence and relevance in key scientific domains, making it an essential resource for those exploring the intersections of genetics and disease pathology.